By contrast, injection of botulinum toxin - including protocols that involve the trigone - is supported by mechanistic human and animal data showing reductions of suburothelial TRPV1, P2X3, and CGRP expression accompanied by symptomatic improvement in OAB/BPS cohorts [31,61]. Here, TRPV1 is linked to Bartsocas-Papas syndrome 1.